000			01628 a2200481 4500
005			20250514074821.0
264		0	_c20040130
008			200401s 0 0 eng d
022			_a0008-6363
024	7		_a10.1016/s0008-6363(03)00367-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aVanWijk, Marja J
245	0	0	_aMicroparticles in cardiovascular diseases. _h[electronic resource]
260			_bCardiovascular research _cAug 2003
300			_a277-87 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAbciximab
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aAntioxidants _xtherapeutic use
650	0	4	_aApoptosis
650	0	4	_aAscorbic Acid _xtherapeutic use
650	0	4	_aBlood Coagulation
650	0	4	_aBlood Platelets _xmetabolism
650	0	4	_aCalcium _xmetabolism
650	0	4	_aCalcium Channel Blockers _xtherapeutic use
650	0	4	_aCardiovascular Diseases _xblood
650	0	4	_aEndothelium, Vascular _xphysiopathology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xtherapeutic use
650	0	4	_aInflammation
650	0	4	_aLipid Metabolism
650	0	4	_aMale
650	0	4	_aMembrane Lipids _xmetabolism
650	0	4	_aPlatelet Activation
650	0	4	_aSubcellular Fractions _xultrastructure
700	1		_aVanBavel, E
700	1		_aSturk, A
700	1		_aNieuwland, R
773	0		_tCardiovascular research _gvol. 59 _gno. 2 _gp. 277-87
856	4	0	_uhttps://doi.org/10.1016/s0008-6363(03)00367-5 _zAvailable from publisher's website
999			_c12683816 _d12683816